DATE : 18-20 JULY 2019
BIOCHEMICAL SOCIETY FOCUSED MEETING
The PI 3-kinase (PI3K) pathway is an intracellular signalling pathway at the crossroads of cell signalling and vesicular traffic. The Biochemical Society last organised a meeting on this topic in 2006 and, since then, the PI3K field has massively expanded. After some challenging years in PI3K pathway drug development, good progress has recently been made, with three PI3K inhibitors now approved for oncology and several others in the registration pipeline.